Applied DNA Company Leadership
| APDN Stock | USD 1.79 0.14 7.25% |
Applied DNA employs about 46 people. The company is managed by 13 executives with a total tenure of roughly 12 years, averaging almost 0.0 years of service per executive, having 3.54 employees per reported executive. Analysis of Applied DNA's management performance can provide insight into the firm performance.
| Judith Murrah President President Secretary |
Applied |
Applied DNA Management Team Effectiveness
The company has return on total asset (ROA) of (0.6375) % which means that it has lost $0.6375 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0345) %, meaning that it created substantial loss on money invested by shareholders. Applied DNA's management efficiency ratios could be used to measure how well Applied DNA manages its routine affairs as well as how well it operates its assets and liabilities.Applied DNA Workforce Comparison
Applied DNA Sciences is number one stock in number of employees category among its peers. The total workforce of Information Technology industry is presently estimated at about 5,040. Applied DNA maintains roughly 46.0 in number of employees contributing less than 1% to equities under Information Technology industry.
The company has Profit Margin (PM) of (2.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.48) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.48. Applied DNA Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Applied DNA insiders, such as employees or executives, is commonly permitted as long as it does not rely on Applied DNA's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Applied DNA insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jantzen Beth few days ago Acquisition by Jantzen Beth of 1961 shares of Applied DNA at 1.08 subject to Rule 16b-3 | ||
Catell Robert B over two weeks ago Acquisition by Catell Robert B of 13606 shares of Applied DNA at 11.04 subject to Rule 16b-3 | ||
Shorrock Clay over a month ago Disposition of 1250 shares by Shorrock Clay of Applied DNA at 47.6 subject to Rule 16b-3 | ||
Shorrock Clay over two months ago Disposition of 135 shares by Shorrock Clay of Applied DNA at 13.2 subject to Rule 16b-3 | ||
Ceccoli Joseph D. over three months ago Acquisition by Ceccoli Joseph D. of 41305 shares of Applied DNA subject to Rule 16b-3 | ||
Montgomery William W over six months ago Acquisition by Montgomery William W of 50000 shares of Applied DNA at 5.25 subject to Rule 16b-3 | ||
Judith Murrah over a year ago Acquisition by Judith Murrah of 150000 shares of Applied DNA subject to Rule 16b-3 | ||
Yacov Shamash over a year ago Applied DNA exotic insider transaction detected |
Applied DNA Notable Stakeholders
An Applied DNA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Applied DNA often face trade-offs trying to please all of them. Applied DNA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Applied DNA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| ScD Hayward | President Chairman | Profile | |
| Judith Murrah | President Secretary | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Warren Pearlson | Sales Consultant | Profile | |
| Tony Benson | Managing EMEA | Profile | |
| Janice Meraglia | G VP | Profile | |
| JD Esq | Chief Development | Profile | |
| Joseph Magno | Sales Consultant | Profile | |
| MeiLin Wan | VP Sales | Profile | |
| John Shearman | Ex Bus | Profile | |
| Beth CPA | Chief Officer | Profile | |
| Sanjay Hurry | Executive Communications | Profile | |
| Stephen Hughes | Director Programs | Profile |
About Applied DNA Management Performance
The success or failure of an entity such as Applied DNA Sciences often depends on how effective the management is. Applied DNA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Applied management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Applied management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York. Applied Dna operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 78 people.
Applied DNA Workforce Analysis
Traditionally, organizations such as Applied DNA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Applied DNA within its industry.Applied DNA Manpower Efficiency
Return on Applied DNA Manpower
| Revenue Per Employee | 74.6K | |
| Revenue Per Executive | 264K | |
| Net Loss Per Employee | 154.1K | |
| Net Loss Per Executive | 545.3K | |
| Working Capital Per Employee | 122.8K | |
| Working Capital Per Executive | 434.6K |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Business Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.